Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-030079
Filing Date
2015-05-13
Accepted
2015-05-13 14:43:04
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v409433_10q.htm 10-Q 213355
2 EXHIBIT 31.1 v409433_ex31-1.htm EX-31.1 9453
3 EXHIBIT 32.1 v409433_ex32-1.htm EX-32.1 4326
  Complete submission text file 0001144204-15-030079.txt   3557727

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20150331_def.xml EX-101.DEF 172228
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20150331_lab.xml EX-101.LAB 224055
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20150331_pre.xml EX-101.PRE 200448
7 XBRL INSTANCE DOCUMENT ttnp-20150331.xml EX-101.INS 558990
8 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20150331.xsd EX-101.SCH 32218
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20150331_cal.xml EX-101.CAL 23070
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27436 | Film No.: 15857824
SIC: 2836 Biological Products, (No Diagnostic Substances)